Evidence map›Paper›PMID 36709269›Full record

ArticleBMC public health2023

Acceptance of COVID-19 vaccine among sub-Saharan Africans (SSA): a comparative study of residents and diasporan dwellers.

Chundung Asabe Miner, Chikasirimobi G Timothy, Khathutshelo Percy, Mashige, Uchechukwu Levi Osuagwu, Esther Awazzi Envuladu, Onyekachukwu Mary-Anne Amiebenomo, Godwin Ovenseri-Ogbomo, Deborah Donald Charwe, Piwuna Christopher Goson and 6 more

Open access · goldAbstract read
In one paragraph

Article in BMC public health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 3 pooled it
7.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 3 syntheses or guidelines pooled it, 28 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Importance of Targeted Communication Strategies During COVID-19 Vaccination Campaigns in Mozambique: Results of a Mixed-Methods Acceptability Study.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 11 institutions in 8 countries.

Chundung Asabe MinerDepartment of Community Medicine, College of Health Sciences, University of Jos, Jos, Plateau State, Nigeria.
Chikasirimobi G TimothyDepartment of Optometry, Mzuzu University, Mzuzu, Malawi.
Khathutshelo Percy
MashigeAfrican Vision Research Institute (AVRI), School of Health Sciences, University of KwaZulu-Natal, Durban, South Africa.
Uchechukwu Levi OsuagwuAfrican Vision Research Institute (AVRI), School of Health Sciences, University of KwaZulu-Natal, Durban, South Africa. l.osuagwu@westernsydney.edu.au.
Esther Awazzi EnvuladuDepartment of Community Medicine, College of Health Sciences, University of Jos, Jos, Nigeria.
Onyekachukwu Mary-Anne AmiebenomoSchool of Optometry and Vision Sciences, College of Biomedical Sciences, Cardiff University, Cardiff, UK.
Godwin Ovenseri-OgbomoAfrican Vision Research Institute (AVRI), School of Health Sciences, University of KwaZulu-Natal, Durban, South Africa.
Deborah Donald CharweTanzania Food and Nutrition Center, Dar-Es-Salaam, Tanzania.
Piwuna Christopher GosonDepartment of Psychiatry, College of Health Sciences, University of Jos, Jos, Plateau State, Nigeria.
Bernadine N EkpenyongAfrican Vision Research Institute (AVRI), School of Health Sciences, University of KwaZulu-Natal, Durban, South Africa.
Emmanuel Kwasi AbuDepartment of Optometry and Vision Science, School of Allied Health Sciences, College of Health and Allied Sciences, University of Cape Coast, Cape Coast, Ghana.
Raymond LangsiHealth Division, University of Bamenda, Bambili, Cameroon.
Richard OloruntobaSchool of Management and Marketing, Curtin University, Kent Street, Bentley, WA, 6102, Australia.
Tanko IshayaDepartment of Computer Science, University of Jos, Jos, Nigeria.
Kingsley E AghoAfrican Vision Research Institute (AVRI), School of Health Sciences, University of KwaZulu-Natal, Durban, South Africa.
University of Jos · NGAfrica Health Research Institute · ZAUniversity of KwaZulu-Natal · ZACardiff University · GBCurtin University · AUMzuzu University · MWTanzania Food and Nutrition Center · TZUniversity of Bamenda · CMUniversity of Calabar · NGUniversity of Cape Coast · GHWestern Sydney University · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe COVID-19 vaccines are being rolled out across all the sub-Saharan Africa (SSA) countries, with countries setting targets for achieving full vaccination rates. The aim of this study was to compare the uptake of, resistance and hesitancy to the COVID-19 vaccine between SSA locally residents and in the diasporan dwellers.

methodsThis was a cross-sectional study conducted using a web and paper-based questionnaire to obtain relevant information on COVID-19 vaccine acceptance. The survey items included questions on demography, uptake and planned acceptance or non-acceptance of the COVID-19 vaccines among SSAs. Multinomial logistic regression was used to determine probabilities of outcomes for factors associated with COVID-19 vaccination resistance and hesitancy among SSA respondents residing within and outside Africa.

resultsUptake of COVID-19 vaccines varied among the local (14.2%) and diasporan (25.3%) dwellers. There were more locals (68.1%) who were resistant to COVID-19 vaccine. Participants' sex [adjusted relative risk (ARR) = 0.73, 95% CI: 0.58 - 0.93], education [primary/less: ARR = 0.22, CI:0.12 - 0.40, and bachelor's degree: ARR = 0.58, CI: 0.43 - 0.77]), occupation [ARR = 0.32, CI: 0.25-0.40] and working status [ARR = 1.40, CI: 1.06-1.84] were associated with COVID-19 vaccine resistance among locals. Similar proportion of local and diasporan dwellers (~ 18% each) were hesitant to COVID-19 vaccine, and this was higher among health care workers [ARR = 0.25, CI: 0.10 - 0.62 and ARR = 0.24, CI:0.18-0.32, diaspora and locals respectively]. After adjusting for the potential confounders, local residents aged 29-38 years [ARR = 1.89, CI: 1.26-2.84] and lived in East Africa [ARR = 4.64, CI: 1.84-11.70] were more likely to report vaccine hesitancy. Knowledge of COVID vaccines was associated with hesitancy among local and diasporan dwellers, but perception was associated with vaccine resistance [ARR = 0.86,CI: 0.82 - 0.90] and hesitancy [ARR = 0.85, CI: 0.80 - 0.90], only among the local residents.

conclusionsDifferences exist in the factors that influence COVID-19 vaccine acceptance between local SSA residents and thediasporan dwellers. Knowledge about COVID-19 vaccines affects the uptake, resistance, and hesitancy to the COVID-19 vaccine. Information campaigns focusing on the efficacy and safety of vaccines could lead to improved acceptance of COVID-19 vaccines.

Indexed as

COVID-19VaccinesAfrican PeopleCOVID-19 VaccinesCross-Sectional StudiesHumansProbabilityVaccinationCOVID-19 VaccinesVaccinesAcceptanceCOVID-19DiasporaHesitancyLocalsResistanceSub-Sahara AfricaVaccination

Identifiers

PMID36709269
PMCPMC9884132
OpenAlexW4318348221

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.